Angewandte Chemie International Edition
10.1002/anie.201904774
COMMUNICATION
C–H annulation in good yields and with excellent
enantioselectivity. As previously noted, substrates with a bulky
alkenyl trimethylsilane group gave product 4d with lower
enantioselectivity. Substrate 3e having a trans-configured 1,2-
disubstituted olefin cyclized in good yield. Pyrrole 3f, bearing the
methyl ester at the 3-position engaged equally well in the
[4]
R. A. Bit, P. D. Davis, L. H. Elliott, W. Harris, E. Keech, H. Kumar,
G. Lawton, A. Maw, J. S. Nixon, D. R. Vesey, J. Wadsworth, S. E.
Wilkinson, C. H. Hill, J. Med. Chem., 1993, 36, 21.
[
5]
6]
M. Gallant et. al., Bioorg. Med. Chem. Lett., 2011, 21, 288.
X.-W. Yang, C.-P. Yang, L.-P. Jiang, X.-J. Qin, Y.-P. Liu, Q.-S. Shen,
Y.-B. Chen, X.-D. Luo, Org. Lett. 2014, 16, 5808.
[
[7]
R. Snoeck et. al., Antiviral Res. 2002, 55, 413.
cyclization, leading to
2
5
a
3:1 mixture of the 5- (4f) and
-annulated (4f’) products. The sterically more accessible
-position was clearly favored and 4f was isolated in 57% yield.
[8]
a) R. J. Sundberg in Indoles, Academic Press, London, 1996; b) D. F.
Taber, P.K. Tirunahari, Tetrahedron, 2001, 67, 7195.
[9]
Selected recent reviews: a) Z. Dong, Z. Ren, S. J. Thompson, Y. Xu, G.
Dong, Chem. Rev. 2017, 117, 9333; b) J. He, M. Wasa, K. S. L. Chan,
Q. Shao, J.-Q. Yu, Chem. Rev. 2017, 117, 8754; c) J. R. Hummel, J. A.
Boerth, J. A. Ellman, Chem. Rev. 2017, 117, 9163; d) D.-S. Kim, W.-J.
Park, C.-H. Jun, Chem. Rev. 2017, 117, 8977; e) K. Murakami, S.
Yamada, T. Kaneda, K. Itami, Chem. Rev. 2017, 117, 9302.
[
10] Selected reviews on enantioselective C–H functionalizations: a) J.
Wencel-Delord, F. Colobert, Chem. Eur. J. 2013, 19, 14010; b) C.
Zheng, S.-L. You, RSC Advances 2014, 4, 6173; c) D.-W. Gao, J.
Zheng, K.-Y. Ye, C. Zheng., S.-L. You in Asymmetric Functionalization
of C–H Bonds, (Ed.: S.-L. You), Royal Society of Chemistry, Cambridge,
U. K., 2015, p. 141. d) C. G. Newton, S.-G. Wang, C. C. Oliveira, N.
Cramer, Chem. Rev. 2017, 117, 8908; e) T. G. Saint-Denis, R.-Y. Zhu,
G. Chen, Q.-F. Wu, J.-Q. Yu, Science 2018, 359, 759.
[
11] a) A. H. Sandtorv, Adv. Synth. Catal. 2015, 357, 2403; b) J. A. Leitch, Y.
Bhonoah, C. G. Frost, ACS Catal. 2017, 7, 5618.
[
12] a) R. K. Thalji, J. A. Ellman, R. G. Bergman, J. Am. Chem. Soc. 2004,
126, 7192; b) R. M. Wilson, R. K. Thalji, R. G. Bergman, J. A. Ellman,
Org. Lett. 2006, 8, 1745; c) S. G. Pan, N. Ryu, T. Shibata, J. Am. Chem.
Soc. 2012, 134, 17474; d) H. Takano, N. Ryu, T. Shibata, Adv. Synth.
Catal. 2015, 357, 1131; e) P.-S. Lee, N. Yoshikai, Org. Lett. 2015, 17,
Scheme 3. Enantioselective C–H functionalization of pyrroles. Reaction
conditions: 5 mol% Ni(cod) , 5.5 mol% L8·HCl, 25 mol% NaOtBu, 0.5 M in
PhCF at 60 °C for 24 h; [a] with 10 mol% Ni(cod) , 11 mol% L8·HCl, 50 mol%
NaOtBu.
2
22; f) D. F. Fernandez, M. Gulias, J. L. Mascarenas, F. Lopez, Angew.
3
2
Chem. Int. Ed. 2017, 56, 9541; g) J. Loup, D. Zell, J. C. A. Oliveira, L.
Ackermann, Angew. Chem. Int. Ed. 2017, 56, 14197; h) F. Pesciaioli, U.
Dhawa, J. C. A. Oliveira, R. Yin, M. John, L. Ackermann, Angew. Chem.
Int. Ed. 2018, 57, 15425.
In conclusion, we have reported highly enantioselective
Ni(0)-catalyzed C−H functionalizations of indoles and pyrroles
without the need for the typical Lewis-basic directing groups.
The reaction provides access to synthetically relevant
tetrahydropyridoindoles and tetrahydroindolizines. Key for the
success of the activation and selectivity in the cyclization was
the development of a new chiral SIPr ligand analogue with very
bulky flanking groups. The work showcases the benefits of the
broad modularity of this chiral carbene ligand class and further
underlines its potential as a general ligand system in different
catalytic enantioselective transformations.
[13] Z. Ding, N. Yoshikai, Angew. Chem. Int. Ed. 2013, 52, 8574.
[14] C. S. Sevov, J. F. Hartwig, J. Am. Chem. Soc. 2013, 135, 2116.
[
15] For representative examples, see: a) P. A. Donets, N. Cramer, J. Am.
Chem. Soc. 2013, 135, 11772; b) G. Song, W. W. N. O, Z. Hou, J. Am.
Chem. Soc., 2014, 136, 12209; c) J. Yang, N. Yoshikai, J. Am. Chem.
Soc. 2014, 136, 16748; d) H. Ohmiya, H. Zhang, S. Shibata, A.
Harada, M. Sawamura, Angew. Chem. Int. Ed. 2016, 55, 4777; e) S.
Fukagawa, Y. Kato, R. Tanaka, M. Kojima, T. Yoshino, S. Matsunaga,
Angew. Chem. Int. Ed. 2019, 58, 1153; f) K. Ozols, Y.-S. Jang, N.
Cramer, J. Am. Chem. Soc. 2019, 141, 5675.
[16] a) P. Gandeepan, T. Mꢀller, D. Zell, G. Cera, S. Warratz, L. Ackermann,
Chem. Rev. 2019, 119, 2192; b) Ł. Woźniak, N. Cramer, Trends Chem.,
2019, DOI:10.1016/j.trechm.2019.03.013.
[
17] a) M. R. Chaulagain, G. J. Sormunen, J. Montgomery, J. Am. Chem.
Soc. 2007, 129, 9568; b) Y. Sato, Y. Hinata, R. Seki, Y. Oonishi, N.
Saito, Org. Lett. 2007, 9, 5597; c) J. S. E. Ahlin, P. A. Donets, N.
Cramer, Angew. Chem. Int. Ed. 2014, 53, 13229; d) R. Kumar, H.
Tokura, A. Nishimura, T. Mori, Y. Hoshimoto, M. Ohashi, S. Ogoshi,
Org. Lett. 2015, 17, 6018; e) P. A. Donets, N. Cramer, Angew. Chem.
Int. Ed. 2015, 54, 633; f) J. S. Ahlin, N. Cramer, Org. Lett. 2016, 18,
Acknowledgements
This work is supported by the Swiss National Science
o
Foundation (n 157741). We thank Dr. R. Scopelliti and Dr. F.
Fadaei Tirani for X-ray crystallographic analysis of compounds
L8·HCl and 2a.
3
242; g) R. Kumar, Y. Hoshimoto, E. Tamai, M. Ohashi, S. Ogoshi, Nat.
Commun. 2017, 8, 32; h) H. Wang, G. Lu, G. J. Sormunen, H. A. Malik,
P. Liu, J. Montgomery, J. Am. Chem. Soc. 2017, 139, 9317; i) Y. Cai,
J.-W. Zhang, F. Li, J.-M. Liu, S.-L. Shi, ACS Catal. 2019, 9, 1.
Keywords: Asymmetric Catalysis • Nickel • Chiral NHC ligands •
C‒H Activation • Heterocycles
[
18] a) Y. Nakao, A. Yada, S. Ebata, T. Hiyama; J. Am. Chem. Soc. 2007,
129, 2428; b) Y. Nakao, Y. Yamada, N. Kashihara, T. Hiyama, J. Am.
Chem. Soc., 2010, 132, 13666. c) S. Okumura, S. Tang, T. Saito, K.
Semba, S. Sakaki, Y. Nakao, J. Am. Chem. Soc. 2016, 138, 14699; d)
W. Guan, G. Zeng, H. Kameo, Y. Nakao, S. Sakaki, Chem. Rec. 2016,
[
[
[
1]
2]
3]
A. Li, Tetrahedron, 2015, 71, 3535.
L. J. Cordrey, J. Am. Geriatr. Soc., 1976, 24, 440.
S. Kurt, Oncology Times, 2014, 36, 39.
16, 2405.
This article is protected by copyright. All rights reserved.